A Reanalysis of the FDA's Benefit-Risk Assessment of Moderna's mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection. [PDF]
Bourdon PS +5 more
europepmc +1 more source
Spike-Specific Memory B Cell Response in Hematopoietic Cell Transplantation Recipients following Multiple mRNA-1273 Vaccinations: A Longitudinal Observational Study [PDF]
Elena Pettini +9 more
openalex +1 more source
Longitudinal evaluation of anti-SARS-CoV-2 neutralizing antibody levels in 3-dose homologous (mRNA-1273- mRNA-1273- BNT162b2) vaccinated kidney transplant population: 18-month follow-up. [PDF]
Karunathilake KRP +9 more
europepmc +1 more source
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines. [PDF]
Bangaru S +19 more
europepmc +1 more source
Safety and Immunogenicity of an mRNA-1273 Booster in Children. [PDF]
Berthaud V +26 more
europepmc +1 more source
mRNA-1273 and Ad26.COV2.S Vaccines Protect Against the B.1.621 Variant of SARS-CoV-2
Tamarand L. Darling +16 more
openalex +1 more source
The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination. [PDF]
Tarriño M +11 more
europepmc +1 more source
Longitudinal Comparison of Three T-Cell Assays and Three Antibody Assays Against SARS-CoV-2 Following Homologous mRNA-1273/mRNA-1273/mRNA-1273 and Heterologous ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naïve Healthcare Workers. [PDF]
Lee H +9 more
europepmc +1 more source

